unknown
Stage
About
DenovAI Biotech develops AI-driven platforms for de novo protein design to create therapeutic antibodies, small protein and peptide biologics, and diagnostic reporters. The company is based in Rehovot, Israel and is a portfolio company of AION Labs.
Explore DenovAI Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.